Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt, +25

Journal of Clinical Oncology

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Alberto Órfão, Meral Beksaç, +29

Haematologica

ImmunohematologyImmunologyPathologyImmunophenotypingPlasma Cells +14

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Kai Neben, Henk M. Lokhorst, Anna Jauch, +22

Blood

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst, +16

Blood

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser, +28

Cancer Cell

Hematological MalignancyCancer ImmunosurveillanceMultiple Myeloma TreatmentImmunologyImmune Checkpoint Inhibitor +6

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Jérôme Moreaux, Friedrich W. Cremer, Thierry Rème, +14

Blood

Embryonic stem cell markers expression in cancers

Matthieu Schoenhals, Alboukadel Kassambara, John De Vos, +3

Biochemical and Biophysical Research Communications

Tumor BiologyMedicineStem CellsCancer GenomicsStem Cell Research +5

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

Michel Jourdan, Anouk Caraux, John De Vos, +7

Blood

Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load

Kai Neben, Anna Jauch, Thomas Hielscher, +8

Journal of Clinical Oncology

CD200 is a new prognostic factor in multiple myeloma

Jérôme Moreaux, Dirk Hose, Thierry Rème, +12

Blood